Fundraising FoxBiocept
San Diego, US · Founded 2013 · Delaware corporation
Find your way into Biocept
Sign up to see every warm intro you have to Biocept
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biocept team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MW
Michael W NallExecutive
LA
Lyle ArnoldExecutive
RT
Raaj TrivediExecutive
VS
Veena SinghExecutive
MF
Mark FolettaExecutive
Board
IR
Ivor RoystonBoard director
EN
Edward NeffBoard director
BA
Bruce A HuebnerBoard director
MA
Marsha A ChandlerBoard director
DF
David F HaleBoard director
MF
M Faye WilsonBoard director
BE
Bruce E GerhardtBoard director
Funding
SEC filings, press & company announcements$3.2M disclosed across 2 of 7 rounds · 2015–2020
- Undisclosed amountregistered direct share offeringApr 2020Source ↗
▶$10.1MofferedJun 2019 · 7 investors · BiotechnologyRule 506(b)
▶$10.1MofferedJun 2019 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce E. GerhardtDirector
- Ivor RoystonDirector
- Bruce HuebnerDirector
- Lyle ArnoldExecutive Officer
- Michael TerryExecutive Officer
- Edwin HendrickExecutive Officer
- Michael NallExecutive Officer, Director
- Timothy KennedyExecutive Officer
- David HaleDirector
- M. Faye WilsonDirector
- Marsha A. ChandlerDirector
- Offering amount
- $10.1M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MofferedMar 2019 · 7 investors · BiotechnologyRule 506(b)
▶$7.4MofferedMar 2019 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ivor RoystonDirector
- M. Faye WilsonDirector
- Timothy KennedyExecutive Officer
- Bruce HuebnerDirector
- Michael NallExecutive Officer, Director
- Marsha A. ChandlerDirector
- Lyle ArnoldExecutive Officer
- David HaleDirector
- Edwin HendrickExecutive Officer
- Michael TerryExecutive Officer
- Bruce E. GerhardtDirector
- Offering amount
- $7.4M
- Sales commissions
- $489.1K
- Finders' fees
- $50K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MofferedOct 2018 · 4 investors · BiotechnologyRule 506(b)
▶$2.4MofferedOct 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- M. Faye WilsonDirector
- Bruce HuebnerDirector
- Michael NallExecutive Officer, Director
- Michael TerryExecutive Officer
- Marsha A. ChandlerDirector
- Bruce E. GerhardtDirector
- Edwin HendrickExecutive Officer
- David HaleDirector
- Ivor RoystonDirector
- Lyle ArnoldExecutive Officer
- Tim KennedyExecutive Officer
- Offering amount
- $2.4M
- Finders' fees
- $175.2K
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.2MraisedAug 2017 · 1 investors · BiotechnologyRule 506(b)
▶$2.2MraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Veena SinghExecutive Officer
- Bruce HuebnerDirector
- Michael NallExecutive Officer, Director
- Lyle ArnoldExecutive Officer
- Ed NeffDirector
- Marsha A. ChandlerDirector
- M. Faye WilsonDirector
- Bruce E. GerhardtDirector
- David HaleDirector
- Ivor RoystonDirector
- Michael TerryExecutive Officer
- Tim KennedyExecutive Officer
- Offering amount
- $4.4M
- Amount sold
- $2.2M
- Finders' fees
- $110K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$5.4MofferedApr 2017 · 13 investors · BiotechnologyRule 506(b)
▶$5.4MofferedApr 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ivor RoystonDirector
- Bruce HuebnerDirector
- Veena SinghExecutive Officer
- Michael TerryExecutive Officer
- Lyle ArnoldExecutive Officer
- Tim KennedyExecutive Officer
- Bruce E. GerhardtDirector
- Michael NallExecutive Officer, Director
- Marsha A. ChandlerDirector
- Ed NeffDirector
- David HaleDirector
- M. Faye WilsonDirector
- Offering amount
- $5.4M
- Sales commissions
- $557.3K
- Finders' fees
- $75K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1MraisedDec 2015 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward NeffDirector
- Michael W NallExecutive Officer, Director
- Lyle ArnoldExecutive Officer
- Bruce A HuebnerDirector
- Marsha A ChandlerDirector
- David F HaleDirector
- Raaj TrivediExecutive Officer
- M Faye WilsonDirector
- Veena SinghExecutive Officer
- Mark FolettaExecutive Officer
- Ivor RoystonDirector
- Bruce E GerhardtDirector
- Offering amount
- $15M
- Amount sold
- $1M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Biocept raised?
- Biocept has disclosed $3.2M raised across 2 of its 7 known rounds.
- Where is Biocept headquartered?
- Biocept is headquartered in San Diego, US.